ARTICLE | Company News
Capstone Therapeutics, LipimetiX deal
August 13, 2012 7:00 AM UTC
Capstone and LipimetiX formed a 60/40 JV, LipimetiX Development LLC, to develop LipimetiX's mimetics of apolipoprotein E (APOE). LipimetiX has rights to the compounds from University of Alabama at B...